MAPT and Alzheimer disease: When analyzed in well-characterized clinical samples, the measurement of Aβ1-42, tau, and phospho-tau in cerebrospinal fluid generally allows the diagnosis of AD and even the prediction of the conversion from MCI to AD with a specificity and sensitivity of about 85% [12].